Illumina unveiled the Billion Cell Atlas, a large‑scale genetic perturbation dataset built with pharma partners to advance AI‑powered drug discovery, target validation, and disease biology.

The Billion Cell Atlas, backed by Eli Lilly, MSD and AstraZeneca, maps mechanisms to support informed drug discovery and ...

Under an alliance framework with AstraZeneca, Merck, and Eli Lilly and Company leading as founding participants, the Atlas is ...

Organoids have now evolved beyond simple experimental models to become next-generation biological platforms that precisely replicate human organ ...

Frost & Sullivan is pleased to announce that BostonGene has been recognized for 2025 Global Technology Innovation Leadership in the ...

Platform integrates proprietary and public genetic and multi-omic data with cutting-edge AI to transform drug discoveryInference Agents autonomously ...

Biology has always been an unruly science. Cells divide when they want to. Genes switch on and off like temperamental lights.

BostonGene, the developer of the leading AI foundation model for tumor and immune biology, today announced a strategic collaboration with AstraZeneca, a global, science-led biopharmaceutical company ...

A new study published in Ecology Letters has uncovered the mechanisms underlying plant community assembly and biodiversity ...

ABSTRACT: This study presents a comprehensive molecular characterization of lactate dehydrogenase (LDH) family members in cervical squamous cell carcinoma (CESC). Through integrated multi-omics ...